A packaged medical device with a white cylindrical cartridge and ten small clear vials containing yellow liquid, shown in a clear blister pack on a dark reflective surface with a blue starry background.
Certificate of Analysis (COA) View the laboratory certificate for this product [ View COA ]

Ipharma tirzepatide 30mg pre filled pen

R 2,100.00
Add to WishlistCompare

TIRZEPATIDE 30mg — Pre-Filled Research Pen

Product Overview
Tirzepatide Pre-Filled Pen is a single-compound peptide formulation supplied for laboratory and research use only. Each multi-dose pen contains 30mg of Tirzepatide, a dual GIP/GLP-1 receptor agonist, supplied with 10 disposable injection needles. Single patient/research-subject use only.

Composition

  • Active peptide: Tirzepatide (GIP/GLP-1 receptor agonist), 30mg
  • Excipients: Disodium phosphate dihydrate, Niacinamide, Phenol, Propylene glycol
  • Format: Multi-dose pre-filled pen
  • Needles: 10 x disposable, 31G, 8mm

Research Overview
Tirzepatide is a dual GIP/GLP-1 receptor agonist that has been extensively studied in published research for its effects on glucose metabolism, insulin sensitivity, and appetite/energy regulation pathways. It is one of the more well-characterized incretin-mimetic compounds in current peptide research literature, with a substantial body of independent data on its receptor activity and metabolic effects.

Key Features

Product Features

  • Pre-filled multi-dose pen format for research convenience
  • Sterile, single-use disposable needles included (x10, 31G/8mm)
  • Dual GIP/GLP-1 receptor pathway compound
  • Subcutaneous research application format

Dosage & Usage

Handling & Storage

  • Store refrigerated at 2–8°C (36–46°F). Do not freeze.
  • Protect from light; keep in original packaging until use.
  • Follow standard cold-chain handling practices once in use.
  • Inspect visually prior to use — do not use if solution is discolored or contains particulate matter.
  • Keep out of reach of children and unauthorized personnel.
  • Dispose of used needles in an approved sharps container per local regulations.
FAQ's & Tips

Q: What is Tirzepatide?
A: A research-grade GIP/GLP-1 dual receptor agonist peptide, supplied strictly for laboratory research purposes.

Q: Is this approved for clinical or personal use?
A: No. This product is sold exclusively for research purposes and is not approved for human consumption, clinical use, or veterinary application.

Q: Is Tirzepatide independently researched?
A: Yes — Tirzepatide has a substantial and well-established body of published research examining its receptor activity and metabolic pathway effects.

Research Applications
Potential research contexts include:

  • Studies on GIP and GLP-1 receptor pathway co-activation
  • Comparative incretin-mimetic compound research
  • Metabolic and endocrine pathway studies
  • Peptide stability and formulation research

Supplied strictly for use by qualified researchers in appropriately licensed laboratory environments. Not intended for diagnostic, therapeutic, or human/veterinary use.

Research

Research OverviewTirzepatide is a dual GIP/GLP-1 receptor agonist that has been extensively studied in published research for its effects on glucose metabolism, insulin sensitivity, and appetite/energy regulation pathways. It is one of the more well-characterized incretin-mimetic compounds in current peptide research literature, with a substantial body of independent data on its receptor activity and metabolic effects.

Reviews